Milam Brantley, Jr., M.D., Ph.D.

Education

M.D., Baylor College of Medicine, Houston, Texas
Ph.D., Baylor College of Medicine, Houston, Texas
B.A., Austin College, Sherman, Texas

Postgraduate Training

Internship

Transitional Medicine, St. John’s Mercy Medical Center, St. Louis, Missouri

Residency

Ophthalmology, Washington University School of Medicine, St. Louis, Missouri

Fellowship

Medical Retina and Inherited Retinal Diseases, Moorfields Eye Hospital, London, UK

Board Certification

American Board of Ophthalmology

Professional Affiliations

American Academy of Ophthalmology
American Society of Retinal Specialists
Association for Research in Vision and Ophthalmology
International Society for Clinical Electrophysiology of Vision

Honors & Awards

NEI K08 Clinician Scientist Career Development Award – 2004
Dennis W. Jahnigen Career Development Award – 2008
Research to Prevent Blindness Special Scholar Award – 2008
Teacher of the Year – Research, Washington University Department of Ophthalmology – 2010

Areas of Clinical Expertise

Retinitis pigmentosa and inherited retinal dystrophies
Retinal electrophysiology
Age-related macular degeneration
Diabetic retinopathy

Research Interests

Genetics of eye diseases
Ocular pharmacogenomics

Background

Dr. Brantley joined the Vanderbilt Eye Institute in 2010 with a focus on Inherited Retinal Diseases and as Director of the Center for Ocular Pharmacogenomics. He specializes in caring for patients with retinal degenerative diseases such as retinitis pigmentosa, Stargardt macular dystrophy, and age-related macular degeneration. Dr. Brantley’s clinical research program investigates the association between gene variants and disease susceptibility as well how genetics influences response to treatment.

To view Dr. Brantley's laboratory research page click here.